Ann: Second Quarter Report FY 2016/17, page-5

There is what everyone has been waiting for, the implementation study results. 76 assessments "Inter rater pain agreement was achieved in 100% of cases and 84% overall when combining both residents at rest and during movement"

These implementation results along with validation results announced last year means they have all the clinical evidence for their TGA and CE mark approval as a Class 1 medical device. All EPT needs is a self declaration statement for the approvals.

Nice to see expanded clinical trials to BUPA and Mercy Health purely for further user feedback and response by carers.

Expected clearance by Q3, deals with all the aged care facilities to be used by professional carers then it will be released to the consumer market. This angle is clever, should build up reputability and gain endorsements from the medical community.

EPT is clearly a smarter, more efficient and accurate pain management tool and leaps and bounds ahead of the Abbey Pain Scale.

Can't see any negatives - only shame is this was not announced pre market!